Article Sidebar
Views pdf: 151
ANALYSIS OF CLINICAL PHARMACIST INTERVENTIONS IN HOSPITALIZED COVID – 19 PATIENTS AT AN INTENSIVE CARE CENTER IN VIETNAM
Main Article Content
Abstract
Introduction: Clinical pharmacists have played a crucial role in managing medications for hospitalised COVID-19 patients. However, quantitative data on pharmacist interventions (PIs) in resource-limited countries are lacking. Objectives: To describe PIs and evaluate their impact on the treatment of hospitalised COVID-19 patient. Materials and Methods: A single-centre, retrospective cross-sectional study was conducted using electronic medical records of all hospitalised COVID-19 patients at University COVID-19 Intensive Care Center (UCICC) from August 2021 to February 2022, who received at least one PI. Impact of each PI was assessed using CLEO tool, which was developed by French Society of Clinical Pharmacy, translated and validated in Vietnam. Results: A total of 2,780 interventions were documented in 567 patients (median: 3 (1; 6) per patient). The most common drug-related problems involved dosage issues (67.0%). The most frequent intervention was therapeutic drug monitoring (30.4%). Antibiotics accounted for 81.9% of all interventions, and 84.0% were accepted by physicians. According to the CLEO tool, 32.1% of interventions had a moderate clinical impact (CL = 2), increased drug-related costs (E = -1), and no organisational impact (O = 0). Conclusion: This study demonstrates the essential role of clinical pharmacists in optimising antibiotic use and therapeutic drug monitoring, and in promoting safe, effective, and cost-conscious inpatient COVID-19 care.
Article Details
Keywords
antibiotics, COVID-19, clinical pharmacist, pharmacist intervention
References
2. Benoît A., Pierrick B., François-Xavier R., et al., Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci, 2006. 28(4): p. 181-8.
3. Ha T.V., Bruno C., Sebastien C., et al., CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists' interventions. Eur J Hosp Pharm, 2021. 28(4): p. 193-200.
4. Maxime P., Morgane M., Anne D., et al., Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital. Eur J Hosp Pharm, 2022. 29(e1): p. e30-e35.
5. Osama A.-Q., Mohammad S., Lana H., Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital. J Pharm Pract, 2022: p. 572-578.
6. Rongrong W., Limin K., Qiang X., et al., On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: A retrospective, observational study. Res Social Adm Pharm, 2021. 17(1): p. 1853-1858.
7. World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification. 2024; Available from: https://www.who.int/tools/atc-ddd-toolkit/atc-classification.
8. Nguyen A.T.-T., Nguyen K.H.-P., Le H.B., et al., Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions. International Journal of Clinical Pharmacy, 2025. 47(1): p. 119-127.